Osteopontin as a biomarker for ovarian cancer [2]

Journal of the American Medical Association

Volumn 287, Issue 24, 2002, Pages 3208-3210

  O'Regan, Anthony ^a   Fleming, Catherine ^a   Seidman, Jeffrey D ^b   Wallach, Robert C ^c   Mok, Samuel C ^d   Skates, Steven J ^d   Berkowitz, Ross S ^d   Cramer, Daniel W ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d DANA FARBER HARVARD CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; LETTER; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; FEMALE; NOTE; OVARY TUMOR;

FEMALE; HUMANS; OSTEOPONTIN; OVARIAN NEOPLASMS; SIALOGLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037178567     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.24.3208     Document Type: Letter

References (0)